| 发明名称 |
GLYCEMIC CONTROL FOR REDUCTION OF CARDIOVASCULAR DISEASE RISK IN DIABETIC PATIENTS EXPRESSING HAPTOGLOBIN 2-2 |
| 摘要 |
This invention relates to methods of reducing risk of developing cardiovascular complications in diabetic patients. Specifically, the invention relates to the use of haptoglobin genotyping for determining the importance of maintaining tight glycemic control in diabetic subjects expressing Hp 2-2 allele. |
| 申请公布号 |
WO2009057119(A2) |
申请公布日期 |
2009.05.07 |
| 申请号 |
WO2008IL01434 |
申请日期 |
2008.11.02 |
| 申请人 |
RAPPAPORT FAMILY INSTITUTE FOR RESEARCH IN THE MEDICAL SCIENCES;LEVY, ANDREW |
发明人 |
LEVY, ANDREW |
| 分类号 |
C12Q1/68 |
主分类号 |
C12Q1/68 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
